Breast cancer resistance protein (BCRP,ABCG2) is an efflux transporter protein that transports various substrates from the cell to the extracellular space or organ cavities. The aim of this study was a complex assessment of the amount of BCRP during pregnancy in rabbits. The amount of BCRP in samples of the rabbit jejunum, liver, kidney, cerebral cortex, and placenta was determined by enzyme immunoassay, and in human hepatocellular carcinoma (HepG2) cells by the Western blot. To study the mechanisms involved in control of the dynamic BCRP levels during pregnancy, serum concentrations of sex hormones were investigated by radioimmunoassay and relative amounts of constitutive androstane receptor (CAR) and pregnane X receptor (PXR) in these organs were evaluated using the Western blot method. The putative role of CAR and PXR in regulation of the BCRP level by progesterone was evaluated in vitro experiments on HepG2 cells. It was found that amount of BCRP in the jejunum of pregnant rabbits was higher than in the placenta, liver, kidneys, and cerebral cortex. An increase in the amount of BCRP in the liver of rabbits was noted on the 21st day of pregnancy and a tendency to the increase was also detected on the 28th day; in the kidney and cerebral cortex increased BCRP levels were detected on the 28th day and 14th day of pregnancy, respectively, as compared with non-pregnant females. In vitro experiments with HepG2 cells have shown that the increase in the BCRP level is determined by the activating effect of progesterone on PXR.
Download PDF:
Keywords: breast cancer resistance protein (BCRP, ABCG2), protein amount, pregnancy, progesterone, constitutive androstane receptor (CAR), pregnane X receptor (PXR)
Citation:
Popova N.M., Slepnev A.A., Abalenikhina Yu.V., Shchulkin A.V., Rokunov E.D., Yakusheva E.N. (2023) Quantitative assessment of breast cancer resistance protein during pregnancy in rabbits. Biomeditsinskaya Khimiya, 69(1), 72-77.
Popova N.M. et al. Quantitative assessment of breast cancer resistance protein during pregnancy in rabbits // Biomeditsinskaya Khimiya. - 2023. - V. 69. -N 1. - P. 72-77.
Popova N.M. et al., "Quantitative assessment of breast cancer resistance protein during pregnancy in rabbits." Biomeditsinskaya Khimiya 69.1 (2023): 72-77.
Popova, N. M., Slepnev, A. A., Abalenikhina, Yu. V., Shchulkin, A. V., Rokunov, E. D., Yakusheva, E. N. (2023). Quantitative assessment of breast cancer resistance protein during pregnancy in rabbits. Biomeditsinskaya Khimiya, 69(1), 72-77.
References
Austin D.L., Ross D.D. (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene, 22(47), 7340-7358. CrossRef Scholar google search
Han L.W., Gao C., Mao Q. (2018) An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus. Expert Opin. Drug Metab. Toxicol., 14(8), 817-829. CrossRef Scholar google search
Gorczyca L., Aleksunes L.M. (2020) Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: A review across tissues and species. Expert Opin. Drug Metab. Toxicol., 16(3), 239-253. CrossRef Scholar google search
Hira D., Terada T. (2018) BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications. Biochem. Pharmacol., 147, 201-210. CrossRef Scholar google search
Wang H., Unadkat J.D., Mao Q. (2008) Hormonal regulation of BCRP expression in human placental BeWo cells. Pharmaceutical Res., 25(2), 444-452. CrossRef Scholar google search
Fuchs I., Hafner-Blumenstiel V., Markert C., Burhenne J., Weiss J., Haefeli W.E., Mikus G. (2013) Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity. Eur. J. Clin. Pharmacol., 69(3), 507-513. CrossRef Scholar google search
Cherian M.T., Lin W., Wu J., Chen T. (2015) CINPA1 is an inhibitor of constitutive androstane receptor that does not activate pregnane X receptor. Mol. Pharmacol., 87(5), 878-889. CrossRef Scholar google search
Skandalaki A., Sarantis P., Theocharis S. (2021) Pregnane X receptor (PXR) polymorphisms and cancer treatment. Biomolecules, 11(8), 1142. CrossRef Scholar google search
Pinheiro E.A., Stika C.S. (2020) Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care. Seminars Perinatology, 44(3), 151221. CrossRef Scholar google search
Jinhu W., Yin Z., Yuhu L. (2020) PXR-ABC drug transporters/ CYP-mediated ursolic acid transport and metabolism in vitro and vivo. Archiv Der Pharmazie, 353(9), 2000082. CrossRef Scholar google search
Whyte-Allman S.K., Hoque M.T., Jenabian M.A., Routy J.P., Bendayan R. (2017) Xenobiotic nuclear receptors pregnane X receptor and constitutive androstane receptor regulate antiretroviral drug efflux transporters at the blood-testis barrier. J. Pharmacol. Exp. Ther., 363(3), 324-335. CrossRef Scholar google search
Gahir S.S., Piquette-Miller M. (2011) Gestational and pregnane X receptor-mediated regulation of placental ATP-binding cassette drug transporters in mice. Drug Metab. Dispos., 39(3), 465-471. CrossRef Scholar google search
Masuyama H., Hiramatsu Y., Mizutani Y., Inoshita H., Kudo T. (2001) The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Mol. Cell. Endocrinol., 172(1-2), 47-56. CrossRef Scholar google search
Meyer zu Schwabedissen H.E., Kim R.B. (2009) Hepatic OATP1B transporters and nuclear receptors PXR and CAR: Interplay, regulation of drug disposition genes, and single nucleotide polymorphisms. Molecular Pharmaceutics, 6(6), 1644-1661. CrossRef Scholar google search
Kachaylo E.M., Pustylnyak V.O., Lyakhovich V.V., Gulyaeva L.F. (2011) Constitutive androstane receptor (CAR) is a xenosensor and target for therapy. Biochemistry (Moscow), 76(10), 1087-1097. CrossRef Scholar google search
